Medicare Enrolled
Dr. Richard Quist, M.D.
Gastroenterology · Newport Beach, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Quist from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Quist?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Quist
Dr. Richard Quist is a gastroenterology specialist in Newport Beach, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Quist performed 2,578 Medicare services across 2,359 unique beneficiaries.
Between the years covered by Open Payments, Dr. Quist received a total of $20,167 from 50 pharmaceutical and/or device companies across 1104 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Quist is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 6% volume in CA
$20,167 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,578
Medicare services
Top 6% in CA for gastroenterology
2,359
Unique beneficiaries
$97
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~136 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
626 | $74 | $120 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
370 | $75 | $663 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
352 | $111 | $1,102 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
229 | $86 | $185 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
210 | $135 | $225 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
189 | $99 | $150 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
168 | $197 | $1,643 |
| Moderate sedation during GI endoscopy Sedation services provided by the physician performing a gastrointestinal endoscopic procedure. This requires an independent trained observer to assist in monitoring the patient. |
97 | $5 | $50 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
54 | $53 | $125 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
50 | $186 | $1,050 |
| Balloon dilation of esophagus, stomach, or upper small bowel, less than 3.0 cm A procedure using a flexible endoscope to widen a narrowed section of the esophagus, stomach, or upper small bowel with a balloon that is less than 3.0 cm in length. |
48 | $107 | $798 |
| Colonoscopy for colorectal cancer screening A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease. |
42 | $190 | $1,050 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
32 | $151 | $1,050 |
| Injection beneath large bowel lining via endoscope A flexible endoscope is used to inject medication or fluid beneath the lining of the large intestine. |
26 | $19 | $494 |
| Upper endoscopy (EGD) A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope. |
22 | $88 | $773 |
| Dilation of esophagus | 20 | $34 | $315 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
16 | $66 | $140 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
14 | $145 | $325 |
| Esophageal function monitoring via capsule This procedure involves monitoring and recording the function of the esophagus using a small capsule attached to the esophageal wall. |
13 | $68 | $300 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$20,167
Total received (2018-2024)
Avg $2,881/year across 7 years
Top 11% in CA for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
1,104
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$20,167 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,862
2023
$3,536
2022
$3,168
2021
$2,299
2020
$834
2019
$2,434
2018
$3,034
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$1,484
AIMMUNE THERAPEUTICS, INC.
$959
Takeda Pharmaceuticals U.S.A., Inc.
$341
Janssen Biotech, Inc.
$313
PFIZER INC.
$286
Lilly USA, LLC
$213
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$195
GENZYME CORPORATION
$168
Phathom Pharmaceuticals, Inc.
$144
Celgene Corporation
$140
Cook Medical LLC
$139
Boston Scientific Corporation
$125
Regeneron Healthcare Solutions, Inc.
$106
Gilead Sciences, Inc.
$87
Ardelyx, Inc.
$59
Madrigal Pharmaceuticals
$45
Exact Sciences Corporation
$22
Celltrion USA Inc.
$19
Intercept Pharmaceuticals, Inc.
$17
Top 3 companies account for 57.3% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$3,964
Janssen Biotech, Inc.
$2,222
AbbVie, Inc.
$1,463
Takeda Pharmaceuticals U.S.A., Inc.
$1,445
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$1,245
AbbVie Inc.
$1,110
AIMMUNE THERAPEUTICS, INC.
$959
PFIZER INC.
$885
Celgene Corporation
$749
Nestle HealthCare Nutrition Inc.
$710
Allergan Inc.
$629
GENZYME CORPORATION
$561
Gilead Sciences, Inc.
$511
UCB, Inc.
$415
Regeneron Healthcare Solutions, Inc.
$371
NESTLE HEALTHCARE NUTRITION INC.
$299
Boston Scientific Corporation
$280
Janssen Scientific Affairs, LLC
$249
Lilly USA, LLC
$247
Synergy Pharmaceuticals Inc
$177
Phathom Pharmaceuticals, Inc.
$144
Cook Medical LLC
$139
Braintree Laboratories, Inc.
$137
E.R. Squibb & Sons, L.L.C.
$119
Merck Sharp & Dohme Corporation
$107
Endogastric Solutions, Inc
$105
Intercept Pharmaceuticals, Inc.
$104
Covidien LP
$100
Ferring Pharmaceuticals Inc.
$97
Ironwood Pharmaceuticals, Inc
$75
Shionogi Inc
$72
Ardelyx, Inc.
$59
Shire North American Group Inc
$48
Prometheus Laboratories Inc.
$47
Madrigal Pharmaceuticals
$45
RedHill Biopharma Inc.
$40
QOL Medical, LLC
$29
Endo Pharmaceuticals Inc.
$24
BOSTON SCIENTIFIC CORPORATION
$24
Exact Sciences Corporation
$22
Medtronic, Inc.
$21
Daiichi Sankyo Inc.
$20
Celltrion USA Inc.
$19
Ethicon US, LLC
$18
Mallinckrodt Hospital Products Inc.
$12
Janssen Pharmaceuticals, Inc
$12
Concordia Pharmaceuticals Inc.
$11
Allergan, Inc.
$11
INTRA-SANA LABORATORIES
$11
Micro-tech Endoscopy USA, Inc.
$5
Top 3 companies account for 37.9% of all-time payments
Associated products mentioned in payments ›
APRISO · Amitiza · Bravo · CLENPIQ · CREON · Cimzia · Cologuard Collection Kit · Creon · DIFICID · DUOPA · DUPIXENT · Dexilant · Donnatal · ECHOTIP INSIGHT · ENTYVIO · EOHILIA · ESOPHYX · EXALT · EXALT BX 2 · EndoFlip · Entyvio · GATTEX · HUMIRA · Humira · IBSRELA · INJECTAFER · INTERSTIM · LINX Reflux Management System · LINZESS · Lesion Hunter · Linzess · MOTEGRITY · MOTOFEN · Mavyret · Motegrity · Mulpleta · NASCOBAL · OCALIVA · OMVOH · PLENVU · RELTONE 200 MG · REMICADE · RESMETIROM · RINVOQ · SIMPONI · SKYRIZI · STELARA · SUFLAVE · SUTAB · Sucraid · Symproic · TREMFYA · TRULANCE · Talicia · Trulance · UCERIS · VEGZELMA · VIBERZI · VOQUEZNA · VOWST · XELJANZ · XIFAXAN · XIFAXANIBSD · ZENPEP · ZEPATIER · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Gastroenterologists within 10 mi
220
Per 100K population
7.0
County median income
$113,702
Nearest hospital
HOAG MEMORIAL HOSPITAL PRESBYTERIAN
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Quist is a clinical cardiology specialist, with above-average Medicare volume (top 6% in CA), with low-engagement industry engagement in the top 11% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Quist experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Quist performed 626 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Quist receive payments from pharmaceutical companies?
Yes. Dr. Quist received a total of $20,167 from 50 companies across 1,104 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Quist's costs compare to other gastroenterologists in Newport Beach?
Dr. Quist's average Medicare payment per service is $97. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Quist) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Newport Beach
Browse gastroenterologists in Newport Beach ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in CA
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in CA
Which CA gastroenterologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology